Twist Bioscience to Present at the 2015 JMP Securities Life Sciences ConferenceDownload PDF
SAN FRANCISCO, Calif. — June 17, 2015 — Twist Bioscience, a company focused on synthetic DNA, today announced that Emily Leproust, Ph.D., chief executive officer of Twist Bioscience, will present at the 2015 JMP Securities Life Sciences Conference on Wednesday, June 24 at 10:30 a.m. Eastern Time at The St. Regis in New York City.
About Twist Bioscience
At Twist Bioscience, our expertise is synthetic DNA. We have developed a proprietary semiconductor-based synthetic DNA manufacturing process featuring a 10,000-well silicon platform capable of producing synthetic biology tools, such as oligonucleotides, genes, pathways, chassis and genomes. By synthesizing DNA on silicon instead of on traditional 96-well plastic plates, our platform overcomes the current inefficiencies of synthetic DNA production, and enables cost-effective, rapid, high-quality and high throughput synthetic gene production. The Twist Bioscience platform has the potential to greatly accelerate the development of personalized medicine, sustainable chemical production, improved agriculture production as well as new applications such as in vivo diagnostics, biodetection and data storage. For more information, please visit www.twistbioscience.com. Twist Bioscience is on Twitter. Sign up to follow our Twitter feed @TwistBioscience at https://twitter.com/TwistBioscience.